Search Within

Weinberg Fellows

Formats
  1. Meeting Abstract (1256)
  2. Journal Article (1061)
  3. Review (108)
  4. Editorial (54)
  5. Research Letter (31)
  6. Book Section (22)
  7. Correspondence (20)
  8. Guidelines (12)
  9. Conference Paper (2)
  10. Miscellaneous (1)
Groups
  1. Department of Medicine (2470)
  2. Solid Tumor Oncology Division (1885)
  3. Hematologic Malignancies, Division of (1191)
  4. GSK Faculty (1125)
  5. Department of Pathology and Laboratory Medicine (917)
  6. Epidemiology and Biostatistics (863)

More Groups

People
  1. Michael Berger (215)
  2. Marc Ladanyi (191)
  3. Pedram Razavi (184)
  4. Michael Offin (173)
  5. David Solit (166)
  6. Maria Carlo (166)

More People

Years
  1. 2025 (152)
  2. 2024 (370)
  3. 2023 (292)
  4. 2022 (347)
  5. 2021 (307)
  6. 2020 (307)

More Years

Publications
  1. Journal of Clinical Oncology (547)
  2. Blood (248)
  3. Annals of Oncology (98)
  4. Clinical Cancer Research (95)
  5. Journal of Thoracic Oncology (82)
  6. Cancer Research (80)

More Publications

Publishers
  1. American Society of Clinical Oncology (618)
  2. Elsevier Inc. (355)
  3. American Society of Hematology (282)
  4. American Association for Cancer Research (217)
  5. Nature Publishing Group (177)
  6. Oxford University Press (147)

More Publishers

Results (2567)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I study of PRT3789, a potent and selective degrader of SMARCA2 in patients with advanced or metastatic solid tumors and a SMARCA4 mutation
    Meeting Abstract

    Dagogo-Jack, I.; Dowlati, A.; Guo, R.; Awad, M. M.; Swalduz, A.; Calvo, E.; Garcia, V. M.; Adjei, A. A.; Lorusso, P.; Punekar, S.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • DB-1305 (a Trop-2 targeted antibody-drug-conjugate [ADC]) in patients (pts) with advanced solid tumors: Preliminary clinical results from the phase (Ph) I/IIa study
    Meeting Abstract

    Marathe, O.; Cheng, Y.; Spira, A. I.; Hamilton, E. P.; Rubinstein, M. M.; Dong, X.; Li, L.; Lv, D.; Shi, J.; Gabrail, N.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Ifinatamab deruxtecan (I-DXd; DS-7300) in patients with advanced solid tumors: Updated clinical and biomarker results from a phase I/II study
    Meeting Abstract

    Patel, M. R.; Doi, T.; Koyama, T.; Falchook, G. S.; Friedman, C. F.; Piha-Paul, S. A.; Gutierrez, M.; Awad, M. M.; Mattour, A. H.; Satoh, T.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Preliminary clinical activity of RMC-6236, a first-in-class, RAS-selective, tri-complex RAS-MULTI(ON) inhibitor in patients with KRAS mutant pancreatic ductal adenocarcinoma (PDAC) and non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Arbour, K. C.; Punekar, S.; Garrido-Laguna, I.; Hong, D. S.; Wolpin, B.; Pelster, M. S.; Barve, M.; Starodub, A.; Sommerhalder, D.; Chang, S.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Genomics of early progression on selpercatinib in patients with RET fusion-positive lung cancers
    Meeting Abstract

    Chen, M. F.; Rosen, E.; Falcon, C.; Repetto, M.; Yang, S. R.; Chang, J.; Kris, M. G.; Rekhtman, N.; Donoghue, M.; Drilon, A.
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Nivolumab plus ipilimumab in advanced salivary gland cancer: A phase 2 trial
    Journal Article

    Vos, J. L.; Burman, B.; Jain, S.; Fitzgerald, C. W. R.; Sherman, E. J.; Dunn, L. A.; Fetten, J. V.; Michel, L. S.; Kriplani, A.; Ng, K. K.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save
  • Challenges and solutions for therapeutic TCR-based agents
    Review

    Malviya, M.; Aretz, Z. E. H.; Molvi, Z.; Lee, J.; Pierre, S.; Wallisch, P.; Dao, T.; Scheinberg, D. A.
    Immunological Reviews (2023)

    Fulltext@MSK | Save
  • Clinical decision support for chemotherapy-induced neutropenia using a hybrid pharmacodynamic/machine learning model
    Journal Article

    Hughes, J. H.; Tong, D. M. H.; Burns, V.; Daly, B.; Razavi, P.; Boelens, J. J.; Goswami, S.; Keizer, R. J.
    CPT: Pharmacometrics and Systems Pharmacology (2023)

    Fulltext@MSK | Save
  • Ototoxicity associated with high-dose carboplatin for patients with previously treated germ cell tumors
    Journal Article

    Funt, S. A.; Knezevic, A.; Wilson, K.; Bromberg, M.; Budnick, A.; O’Connor, K. L.; McHugh, D. J.; Larsen, E.; Bajorin, D. F.; Motzer, R. J.; more...
    Cancer (2023)

    Fulltext@MSK | Save
  • Radiation and immune checkpoint inhibitors: Combination therapy for treatment of hepatocellular carcinoma
    Review

    Chami, P.; Diab, Y.; Khalil, D. N.; Azhari, H.; Jarnagin, W. R.; Abou-Alfa, G. K.; Harding, J. J.; Hajj, J.; Ma, J.; El Homsi, M.; more...
    International Journal of Molecular Sciences (2023)

    Fulltext@MSK | Save